Endocrine-disrupting chemical exposure during differentiation alters the proliferation–maturation balance in stem-cell islets
Toxicological Sciences · 2026
DOI: 10.1093/toxsci/kfaf163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, 2026. Verfasst von June H Gudmestad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway. Hauptthemen laut MEDLINE: Endocrine Disruptors, Cell Differentiation, Cell Proliferation, Islets of Langerhans. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Thomas A. Legøy and the Research Council of Norway, Norwegian Diabetes Association with Diabetesforbundets forskningsfond, NIGMS NIH HHS.
Abstract (Originalsprache)
Exposure to endocrine-disrupting chemicals (EDCs) is increasingly recognized as a risk factor for diabetes, primarily through disruption of pancreatic beta-cell function and insulin signaling. These effects can arise not only from adult exposure but also during development, as many EDCs can cross the placental barrier. However, models that accurately mimic human pancreatic islet development are limited. In this study, we reported the first toxicological application of stem cell islets (SC-islets) to investigate the developmental effect of EDCs. Using human-induced pluripotent stem cells (iPSCs), we generated SC-islets and exposed them to a mixture of bisphenol A, bisphenol S, and trans-nonachlor during differentiation. EDC exposure resulted in SC-islets with an altered transcriptional profile, characterized by reduced expression of beta-cell maturity markers, increased proliferation markers, and elevated KI67-positive cell counts. These features resembled earlier developmental stages and deviated from mature human islet profiles, suggesting a delay in differentiation. Our findings establish SC-islet differentiation as a novel and relevant in vitro model for assessing the developmental toxicity of EDCs, with outcomes consistent with in vivo studies. This model opens new avenues for mechanistic studies and chemical safety assessment in endocrine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
- Department of Cell Biology, Harvard Medical School, Boston, MA 02115, United States.
ORCID-Profile: Lucas Unger, Thomas A Legøy
Förderung
- Thomas A. Legøy and the Research Council of Norway
- Norwegian Diabetes Association with Diabetesforbundets forskningsfond
- NIGMS NIH HHS
- National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
Zitieren
APA
Gudmestad, J. H., Unger, L., Paulo, J. A., Ghila, L., & Legøy, T. A. (2026). Endocrine-disrupting chemical exposure during differentiation alters the proliferation–maturation balance in stem-cell islets. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf163
Vancouver
Gudmestad JH, Unger L, Paulo JA, Ghila L, Legøy TA. Endocrine-disrupting chemical exposure during differentiation alters the proliferation–maturation balance in stem-cell islets. Toxicological Sciences. 2026. doi:10.1093/toxsci/kfaf163
BibTeX
@article{Gudmestad2026,
author = {Gudmestad, June H and Unger, Lucas and Paulo, Joao A and Ghila, Luiza and Legøy, Thomas A},
title = {Endocrine-disrupting chemical exposure during differentiation alters the proliferation–maturation balance in stem-cell islets},
journal = {Toxicological Sciences},
year = {2026},
doi = {10.1093/toxsci/kfaf163}
}
EUVIMED